6008 caresystem - renal society of australasia...the environmental impact and financial cost of...

8
6008 CAREsystem Maximising Simplicity Haemodialysis Giving quality time for what matters most

Upload: others

Post on 29-Jan-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

  • 6008 CAREsystem Maximising Simplicity

    Haemodialysis

    Giving quality time for what matters most

  • Special wetness detector for quick detection of blood loss

    especially for patients undergoing nocturnal dialysis, as well

    as restless or confused patients

    6008 CAREsystem - the next step in innovative hemodialysis solutions

    The 6008 CAREsystem allows you to deliver beneficial

    therapies with many advantages to better meet the

    demands of a modern day dialysis environment.The 6008

    CAREsystem continues Fresenius Medical Care’s

    commitment to delivering beneficial therapies, while

    optimizing dialysis treatments and improving efficiency.

    Automated and non-invasive blood-pressure monitoring

    (systolic and diastolic blood pressure, MAP, pulse)

    The Therapy Data Management System (TDMs) is

    seamlessly integrated into existing work flow processes and

    supports the user in their daily tasks

    6008 CAREsystem

    Optimized monitoring of the venous path increasing the

    probability of early detection of venous needle

    dislodgement

    Calculates the adequacy of delivered dialysis dose (Kt/V) in

    accordance with guidelines1, 2

    By achieving high substitution volumes of ≥21L19,

    HighVolumeHDF® therapies are credited with more effective

    elimination of middle molecules thus improving patient

    outcomes and exerting beneficial effects on the main

    cardiovascular risk factors

    The all-in-one 6008 CAREset with

    its pre-connected bloodlines,

    compact design and lightweight

    material covers all treatment

    modalities and enables automatic

    connection to the integrated

    substitution unit on the 6008

    CAREsystem

    Maintains constant core body temperature for better

    hemodynamic stability during dialysis3

    3

    * optional

    *VenAccEXTERNAL WIRELESS WETNESS DETECTOR

    6008 CAREsystem - the next step ininnovative haemodialysis solutions

    The 6008 CAREsystem allows you to deliver beneficial

    therapies with many advantages to better meet the

    demands of a modern day dialysis environment.

    6008 CAREsystem

    The all-in-one 6008 CAREset withits pre-connected bloodlines,compact design and lightweightmaterial covers all treatment modalities and enables automatic connection to the integrated substitution unit on the 6008 CAREsystem (NB: for paediatrics there is a separate low volume

    bloodline)

    Automated and non-invasive blood-pressure monitoring(systolic and diastolic blood pressure, MAP, pulse)

    Special wetness detector for quick detection of blood loss especially for patients undergoing nocturnal dialysis,

    as well as restless or confused patients

    The Therapy Data Management System (TDMS) is seamlessly integrated into existing work flow processes

    and supports the user in their daily tasks

    *optional

  • Special wetness detector for quick detection of blood loss

    especially for patients undergoing nocturnal dialysis, as well

    as restless or confused patients

    6008 CAREsystem - the next step in innovative hemodialysis solutions

    The 6008 CAREsystem allows you to deliver beneficial

    therapies with many advantages to better meet the

    demands of a modern day dialysis environment.The 6008

    CAREsystem continues Fresenius Medical Care’s

    commitment to delivering beneficial therapies, while

    optimizing dialysis treatments and improving efficiency.

    Automated and non-invasive blood-pressure monitoring

    (systolic and diastolic blood pressure, MAP, pulse)

    The Therapy Data Management System (TDMs) is

    seamlessly integrated into existing work flow processes and

    supports the user in their daily tasks

    6008 CAREsystem

    Optimized monitoring of the venous path increasing the

    probability of early detection of venous needle

    dislodgement

    Calculates the adequacy of delivered dialysis dose (Kt/V) in

    accordance with guidelines1, 2

    By achieving high substitution volumes of ≥21L19,

    HighVolumeHDF® therapies are credited with more effective

    elimination of middle molecules thus improving patient

    outcomes and exerting beneficial effects on the main

    cardiovascular risk factors

    The all-in-one 6008 CAREset with

    its pre-connected bloodlines,

    compact design and lightweight

    material covers all treatment

    modalities and enables automatic

    connection to the integrated

    substitution unit on the 6008

    CAREsystem

    Maintains constant core body temperature for better

    hemodynamic stability during dialysis3

    3

    * optional

    *VenAccEXTERNAL WIRELESS WETNESS DETECTOR

    Optimised monitoring of the venous pressure profile increasing the probability of early detection of venous

    needle dislodgement

    Calculates the adequacy of delivered dialysis dose (Kt/V) and allows for real-time monitoring

    of each and every dialysis

    Maintains constant core body temperature to promote

    better haemodynamic stability during dialysis

    HighVolumeHDF®Haemodiafiltration (HDF) with 20–22L of substitution fluid is increasingly recognised as associated with

    significant benefits regarding patient outcome1

  • 6008 CAREsystem

    TherapyMaximising

    CostOptimisation

    Maximising

    Patient CareMaximising

    Simplicity andAutomation

    Maximising

  • Maximising Therapy

    Maximising Cost Optimisation

    The 6008 CAREsystem delivers improved patient benefits by providing HighVolumeHDF® as a standard therapy with automatic maximisation of the substitution volume through AutoSub plus2. AutoSub plus feature automatically measures and evaluates the flow conditions directly inside the filter several times per minute to deliver precise information on the conditions in and across the dialyser membrane. As a result, substitution volumes can individually be maximised for every patient without any user interaction.

    FX CorDiax HDF filters deliver optimal flow conditions assuring effective middle molecule removal while minimising albumin loss. This assists in achieving the full benefits of HighVolumeHDF® therapy.

    Cost-effective production of ONLINE sterile and non-pyrogenic substitution fluid is possible on the 6008 CAREsystem with the DIASAFE® plus filters.

    Increased simplicity is assured with the all-in-one 6008 CAREset with pre-connected bloodlines that covers all treatment modalities including HD, HighVolumeHDF® (pre/post), HF (pre/post), and SN (HD/HDF).2

    More eco-friendly and sustainable

    The environmental impact and financial cost of dialysis through waste management can be significant. The 6008 CAREset is compact in design, utilises a lightweight material and with its automatic emptying of disposables at the end of treatment, results in reduced waste disposal weight for the dialysis unit4.

    Inventory control can also be challenging in the dialysis unit given the requirement for a multitude of consumables and the limited storage space in some dialysis units. The all-in-one 6008 CAREset helps to overcome this challenge by offering:

    • A streamlined inventory and simplified ordering process

    • A lower storage space requirement

    • The all-in-one 6008 CAREset and covers all treatment modalities with no additional bloodlines are required for therapies such as HD, HighVolumeHDF® (pre/post), HF (pre/post), and SN (HD/HDF) (NB: Paediatric low volume bloodlines are different)

    • Working towards reducing our carbon footprint with the compact design and lightweight material.

  • Maximising Patient Care

    Maximising Simplicity and Automation

    Workflow improvements:

    In order to maximise safety in therapy delivery, the workflow processes have been simplified and automated to reduce major handling steps during a HighVolumeHDF® treatment versus a conventional system thereby saving on set up time.3

    Key time-saving steps:

    • Eliminates the need to connect the substitution line after T1 test

    • The ONLINE closed-circuit reinfusion reduces the need for arterial disconnection for the reinfusion process

    • Automatic emptying of the extracorporeal circuit at the end of treatment.

    Giving you more confidence

    The 6008 CAREsystem may decrease the risk of cross contamination through the reduced number of work flow steps and touch points with automatic connection to the integrated substitution unit for ONLINE priming and rinsing combined with the ONLINE closed circuit reinfusion.

    The 6008 CAREsystem enables a 27% reduction in process steps and touch points for a fistula patient and a 23% reduction in process steps and touch points for catheter patients during a HighVolumeHDF® treatment.2

    ConnectSubstitution line

    ArterialDis-Connection

    Startemptying

    T1 Test / Mounting Priming

    Connect patient Treatment

    Dis-connect patient

    Emptying bloodline

    Dis-mantling

    Re-infusion

    Treatment Steps Redundant Steps

  • Disclaimer

    All information and contents of this material are for general informational purposes only and are provided by Fresenius Medical Care group of companies without any warranties or representations of any kind either express or implied, including without limitation as to their accuracy, completeness or correctness.

    None of the information contained in this material is a substitute for professional medical or health advice, examination or recommended treatments. Patients are advised to consult their physician or other licensed healthcare providers. Healthcare professionals are solely responsible for making their own independent evaluation as to the efficacy or suitability of any products or services for any particular purpose.

    The availability of products or services mentioned in this material is subject to regulatory requirements and product or service registration status in each country, and products and technical specifications may change without notice. Please contact one of the representatives of Fresenius Medical Care in your country for more details.

    All information and contents of this material shall be subject to change and shall not be binding. The Fresenius Medical Care group of companies expressly reserves the right without issuing separate notice to amend, supplement or delete parts of the contents of this material or to suspend or permanently withdraw their publication at any time and at its sole discretion. In no event shall any Fresenius Medical Care group company be held liable for any direct, indirect, incidental, consequential or punitive damages, lost profits, lost data or any other loss or damage arising out of your use of and/or access to, this material or from your reliance on or reference to, any information provided in this material.

    All photography contained in this material is for illustrative purposes only and all persons shown in photographs are licensed stock photography models and are not actual patients nor are they affiliated with the Fresenius Medical Care group or any patients. The Fresenius Medical Care group of companies assumes no liability whatsoever for any consequence relating directly or indirectly to the use of the photographs showing the models in this material.

    The names marked with ® or TM are registered trademarks of Fresenius Medical Care or Fresenius Group in selected countries.

    For more details please refer to the 6008 CAREsystem Technical Specifications in the Instructions For Use (IFU).

    Instructions for Use - Fresenius Medical Care 6008 CAREsystem, Software version: 2.46, Edition: 21A-2018 Fresenius Medical Care AG &

    Co. KGaA D-61346 Bad Homburg +49 (0) 6172-609-0.

    References: 1. Marcelli et al., Artificial Organs (2015); 39(2):142–149.

    2: Tsobanelis T. et al., Haemodiafiltration relative risk: A comparative analysis of two dialysis machines, Nephrol Dial Transplant (2016); 31(1): i536-i557.

    3: Workflow Analysis by REFA, 6008 CAREsystem in comparison to Therapy System 5008 (patients with fistula), March 2016. Non-published data.

    4: Schleser A. et al., The impact of disposables towards more eco-friendly and less costly Hemodialysis, Nephrology Dialysis Transplantation (2016); 31(1): i489-i502.

    .

  • AN

    Z046

    Jul

    y 20

    20 ©

    cop

    yrig

    ht 2

    020

    Fres

    eniu

    s M

    edic

    al C

    are

    Aus

    tral

    ia P

    ty L

    td. A

    ll R

    ight

    s R

    eser

    ved

    Fresenius Medical Care Australia Pty Ltd. Level 27, 100 Miller Street, North Sydney NSW 2060. ABN 80 067 557 877 Phone: (61) 2 9466 8000 Fax: (61) 2 9929 5595 www.fmc-au.com July 2020. ATSF 7095 BBK 07/20